News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pharmatek Laboratories, Inc. Receives DEA Registration for Handling Controlled Substances


2/17/2010 9:05:46 AM

SAN DIEGO, Feb. 17 /PRNewswire/ -- Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has successfully met Drug Enforcement Agency (DEA) requirements to be registered for the development and manufacture of Schedule IV and V controlled substances.

Controlled substances are designated as Schedule I-V according to their medical use, potential for abuse and safety or dependence liability. In order to research, manufacture or distribute a controlled substance, a person or entity must be audited and registered by the DEA.

About Pharmatek Laboratories, Inc.

Pharmatek Laboratories Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, and cytotoxic and high-potency development.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Timothy M. Scott

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=50335

Jeffrey A. Bibbs

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=48157

CONTACT: Ryan Lane, Marketing Coordinator of Pharmatek Laboratories, Inc.,
+1-858-805-6383 x284, rlane@pharmatek.com

Web site: http://www.pharmatek.com/


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES